| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Jeffrey F Odonnell last filed a Form 4 in February 2021, as Director at STEX. Jeffrey F Odonnell's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 151,629 shares of STEX. The STEX filings lean toward selling, a net 100,000 shares.
Jeffrey F Odonnell has 21 Form 4 filings on record from July 2015 to February 2021, across 2 companies: Director at Streamex (STEX), 2015–2021; Director at STRATA Skin Sciences (SSKN), 2015–2017.
The 23 reported transactions were 7 option or other derivative awards, 6 stock awards, 5 gifts and 2 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $9K and 1 sale worth about $530K.
The only open-market purchase was 5,000 shares of STEX at an average $1.82 on July 20, 2015, about $9K.
The only open-market sale was 105,000 shares of STEX at an average $5.05 on February 8, 2021, about $530K.
Shares as reported in the last Form 4 for each company; the most recent is from February 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.